You are on page 1of 23

GNIPST BULLETIN 2017

31-03-2017

31st March, 2017 Volume No.: 65 Issue No.: 03

Vision
To develop responsible citizens who would be professionally equipped to think globally and act
locally and become reformers of society to meet the challenges of future.
Mission
To impart high quality pharmaceutical science, technology and management education to the budding
professionals and provide the ambience needed for developing requisite skills to make a mark of
excellence in Education, Research, Business , Industry and achieve highest personal standards.

Contents
Message from PRINCIPAL
Editorial board
Historical article
News Update
Knowledge based Article
Disease Related Breaking News
Upcoming Events
Drugs Update
Campus News
Students Section
Editors Note
Archive

GNIPST Photo Gallery


For your comments/contribution
OR For Back-Issues,
mailto:gnipstbulletin@gmail.com

GURU NANAK INSTITUTE OF PHARMACEUTICAL


SCIENCE AND TECHNOLOGY
Website: http://gnipst.ac.in
31-03-2017

MESSAGE FROM PRINCIPAL

"It can happen. It does happen.


But it can't happen if you quit." Lauren Dane.

We are what we repeatedly do.


Excellence then is not an act, but a habit. Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the
last years editors and congratulate the newly selected editors for the current year.

Our first consideration is always in the best interest of the students. Our goal is to promote academic
excellence and continuous improvement.

I believe that excellence in education is aided by creating a learning environment in which all learners are
supported in maximizing their potential and talents. Education needs to focus on personalized learning
and instruction, while promoting an education system that is impartial, universally accessible, and meeting
the needs of all students.

It is of paramount importance that our learners have sufficient motivation and encouragement in order to
achieve their aims. We are all very proud of you, our students, and your accomplishments and look
forward to watching as you put your mark on the profession in the years ahead.

The call of the time is to progress, not merely to move ahead. Our progressive Management is looking
forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in
this direction and fruits of these efforts will be received by our students in the near future. Our Teachers
are committed and dedicated for the development of the institution by imparting their knowledge and play
the role of facilitator as well as role model to our students.

The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive
challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic
needs of our students.

I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the
opportunities and meet the challenges with purpose and determination.

Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on
this path.

My best wishes to all.

Dr. A. Sengupta

Click here to go at the top

1
31-03-2017

EDITORIAL BOARD
CHIEF EDITOR DR. ABHIJIT SENGUPTA
EDITOR MS. JEENATARA BEGUM
ASSOCIATE EDITOR MR. DIPANJAN
MANDAL

HISTORICAL ARTICLE
Thomas Alva Edison
Thomas Alva Edison is one of the greatest American inventors who
held countless patents, majority of them related to electricity and
power. While two of his most famous inventions are the
incandescent lamp and the phonograph, arguably the most
significant invention of Edison is considered to be organized
research.
Early Life:
Edison was born on February 11, 1847 in the historic city of Milan
(Ohio). His father was a versatile person and a man-of-all-work,
while his mother was a teacher. Edison was mostly homeschooled
by his mother. Edison became a salesman of fruit, paper and other
goods on the Grand Trunk Railroad at a tender age of 12. With the
help of his tiny handpress in a trash car, he wrote and published
the Grand Trunk Herald in 1862, which was sent to 400 railroad
employees. The same year Edison worked as a telegraph operator,
trained by the father of a kid whose life he had saved. Edison was a
tramp telegrapher, as he was exempted from military service due
to his deafness. He was recruited in 1868 by Western Union
Telegraph Company in Boston.
Early Conceptions:
Perhaps the first invention of Edison was a telegraph repeater in
1864 which worked automatically, while his earliest patent was
registered for an electric vote recorder. He acquired partnership in
a New York electrical company in 1869, where he honed the stock
ticker and sold it. With all his money, Edison paid for his own

Click here to go at the top

2
31-03-2017

factory in Newark, N.J., where he hired technicians to help him


with the inventions. His dream was to create an invention
factory. Almost 80 earnest men, including physicists,
mathematicians and chemists, were among his collaborators.
Invention to order made him good money at this place.
From 1870 to 1875 Edison devised many telegraphic advances
including receivers, transmitters, the duplex, tape and automatic
printers. He also collaborated in 1871 with Christopher Sholes, also
known as father of the typewriter, to ameliorate the typing
machine. Edison claimed to have made twelve typewriters at
Newark in 1870. As a result, the Remington Company purchased
his interests.
Edisons carbon telegraph transmitter for Western Union brought
a breakthrough for the creation of the Bell telephone. The money
he got from Western Union for the transmitter was spent to
establish a factory in Menlo Park, N.J. One more time, he used
scientific talent to register over 300 patents in only 6 years. His
electric pen (1877) developed stencils to produce copies.
Other Inventions and Contributions:
Probably his most impressive invention, the phonograph, was
patented in 1877. By 1890 Edison had about 80 patents under his
name, and that was pretty much the reason The Victor Company
came into being.
To explore incandescence, Edison and his fellows, among them J.
P. Morgan, developed the Edison Electric Light Company in 1878.
Years later, the company became the General Electric Company.
Edison invented the first practical incandescent lamp in 1879.
With months of hard work researching metal filaments, Edison
and his staff analyzed 6,000 organic fibers around the world and
determined that the Japanese bamboo was ideal for mass
production. Large scale production of these cheap lamps turned
out to be profitable, hence the first fluorescent lamp was patented
in 1896.
Edison made an amazing discovery in pure science, termed as the
Edison Effect. He discovered in 1883 that electrons flowed from

Click here to go at the top

3
31-03-2017

incandescent filaments. The lamp could function as a valve using a


metal-plate insert, while taking only negative electricity. A method
to transmit telegraphic aerial signals over short distances was
patented by Edison in 1885. The wireless patent was later sold to
Guglielmo Marconi.
The huge West Orange, N.J., factory was supervised from 1887 to
1931 by Edison. This was probably the worlds most cutting-edge
research laboratory, and a forerunner to modern research and
development laboratories, with experts systematically
investigating and researching for the solution of problems.
The Edison battery, made perfect in 1910, used an alkaline
electrolyte, and proved to be a superb storage device. The copper
oxide battery, strikingly similar to modern dry cells, was modified
in 1902.
The kinetograph, his motion picture camera, was able to
photograph action on 50-foot strips of film, and produced about
sixteen images per foot. A young assistant of Edison built a small
laboratory in 1893 called the Black Maria, which was substantial
in making the first Edison movies. The kinetoscope projector of
1893 finally displayed the films. The earliest commercial movie
theater, a peepshow, was established in New York in 1884. After
developing and modifying the projector of Thomas Armat in 1895,
Edison commercialized it as the Vitascope.
The Edison Company created over 1,700 movies. Edison set the
benchmark for talking pictures in 1904 by synchronizing movies
with the phonograph. His cinemaphone adjusted the film speed to
phonograph speed. The kinetophone projected talking pictures in
1913. The phonograph, behind the screen, was synchronized by
pulleys and ropes with the projector. Edison brought forth many
talkies.
The universal motor, which utilized alternating or direct current,
appeared in 1907. The electric safety lantern, patented in 1914,
significantly reduced casualties among miners. The same year
Edison devised the telescribe, which unified characteristics of the
telephone and dictating phonograph.

Click here to go at the top

4
31-03-2017

Services for the Government:


Edison presided the U.S. Navy Consulting Board throughout
World War I and made 45 more inventions. These inventions
included substitutes for antecedently imported chemicals (such as
carbolic acid), a ship-telephone system, an underwater searchlight,
defensive instruments against U-boats, among others. Later on,
Edison launched the Naval Research Laboratory, the eminent
American institution for research involving organized weapons.
Death:
This multi-genius died on Oct. 18, 1931 in West Orange, N.J. The
laboratory buildings and equipment affiliated with Edison were
upheld in Greenfield Village, Detroit, Michigan by Henry Ford, a
friend and admirer.

NEWS UPDATE
Preclinical research: More reliably predicting
what will work: (31st March, 2017)
A recent study has shown that a more flexible approach to study
design can significantly improve the efficiency of preclinical
research.
Genes associated with Erdheim-Chester disease
also linked to cancer: (31st March, 2017)
Newly identified genes associated with Erdheim-Chester disease
(ECD), an ultra-rare disease, are also linked to cancer, according to
a new study. Thus, ECD should be considered a type of cancer and
treated by oncologists. A new clinical trial -- enrolling ECD
patients now -- will test the use of the drugs dabrafenib and
trametinib.
Experimental small molecule shows potential in
preventing meth relapse: (31st March, 2017)
The reason methamphetamine users find it so hard to quit -- 88
percent of them relapse, even after rehab -- is that meth takes
advantage of the brain's natural learning process, say scientists.
Click here to go at the top

5
31-03-2017

Helping the retina regenerate: (31st March,


2017)
A new report gives recommendations for regenerating retinal
ganglion cells (RGCs), crucial neurons in the back of the eye that
carry visual information to the brain.
Children with autism find understanding facial
expressions difficult but make similar mistakes
as peers, new study finds: (31st March, 2017)
Young people with autism spectrum conditions (ASC) have
difficulties recognizing and distinguishing between different facial
expressions, according to research from one of the largest studies
to look at emotion recognition in children and adolescents with
ASC.
A new approach to amplifying DNA: (31st
March, 2017)
Analyzing DNA is useful for a number of vital applications. This
includes diagnosis and monitoring of diseases, identification of
criminals, and studying the function of a targeted segment of DNA.
However, methods used for analyses often require more DNA than
may be available in a typical sample. A new polymerase chain
reaction method could help the amplification process, and thus
develop robust assays that previously would not have been
possible.
For detail mail to editor

KNOWLEDGE BASED ARTICLE


FDA approves new eczema drug Dupixent
The U.S. Food and Drug Administration approved Dupixent
(dupilumab) injection to treat adults with moderate-to-severe
eczema (atopic dermatitis). Dupixent is intended for patients
whose eczema is not controlled adequately by topical therapies, or

Click here to go at the top

6
31-03-2017

those for whom topical therapies are not advisable. Dupixent can
be used with or without topical corticosteroids.
FDAs approval of Dupixent demonstrates our commitment to
approving new and innovative therapies for patients with skin
disease, said Julie Beitz, M.D., director of the Office of Drug
Evaluation III in the FDAs Center for Drug Evaluation and
Research. Eczema can cause significant skin irritation and
discomfort for patients, so it is important to have a variety of
treatment options available to patients, including those patients
whose disease is not controlled by topical therapies.
Atopic dermatitis, a chronic inflammatory skin disease, is often
referred to as eczema, which is a general term for several types of
inflammation of the skin. Atopic dermatitis is the most common of
the many types of eczema; onset typically begins in childhood and
can last through adulthood. The cause of atopic dermatitis is a
combination of genetic, immune and environmental factors. In
atopic dermatitis, the skin develops red, scaly and crusted bumps,
which are extremely itchy. Scratching leads to swelling, cracking,
weeping clear fluid, and finally, coarsening and thickening of the
skin.
Dupixent is administered as an injection under the skin.
Dupixents active ingredient is an antibody (dupilumab) that
binds to a protein [interleukin-4 (IL-4) receptor alpha subunit (IL-
4Ra)], that causes inflammation. By binding to this protein,
Dupixent is able to inhibit the inflammatory response that plays a
role in the development of atopic dermatitis.
The safety and efficacy of Dupixent were established in three
placebo-controlled clinical trials with a total of 2,119 adult
participants with moderate-to-severe atopic dermatitis not
adequately controlled by topical medication(s). Overall,
participants who received Dupixent achieved greater response,
defined as clear or almost clear skin, and experienced a reduction
in itch after 16 weeks of treatment.
Dupixent can cause side effects such as serious allergic reactions
and eye problems, such as pink eye (conjunctivitis) and

Click here to go at the top

7
31-03-2017

inflammation of the cornea (keratitis). If patients experience new


or worsening eye symptoms such as redness, itching, pain or visual
changes, they should consult a health care provider. The most
common side effects include injection site reactions; cold sores in
the mouth or on the lips; and eye and eyelid inflammation,
including redness, swelling and itching.
The safety and efficacy of Dupixent have not been established in
the treatment of asthma. Patients who also have asthma should not
adjust or stop their asthma treatment without talking to their
physicians.
The FDA granted the approval of Dupixent to Regeneron
Pharmaceuticals, Inc.
The FDA, an agency within the U.S. Department of Health and
Human Services, protects the public health by assuring the safety,
effectiveness, and security of human and veterinary drugs, vaccines
and other biological products for human use, and medical devices.
The Agency also is responsible for the safety and security of our
nations food supply, cosmetics, dietary supplements, products
that give off electronic radiation, and for regulating tobacco
products.
Jeenatara Begum
Assistant Professor
GNIPST

DISEASE RELATED BREAKING NEWS


Yellow fever Suriname: (28th March, 2017)
On 9 March 2017, the National Institute for Public Health and the
Environment (RIVM) in the Netherlands reported a case of yellow
fever to WHO. The patient is a Dutch adult female traveller who
visited Suriname from the middle of February until early March
2017. She was not vaccinated against yellow fever.
The case was confirmed for yellow fever in the Netherlands by RT-
PCR in two serum samples taken with an interval of three days at
the Erasmus University Medical Center (Erasmus MC),
Rotterdam. The presence of yellow fever virus was confirmed on 9
Click here to go at the top

8
31-03-2017

March 2017 by PCR and sequencing at Erasmus MC, and by PCR


on a different target at the Bernhard Nocht Institute for Tropical
Medicine, Hamburg, Germany.
While in Suriname, the patient spent nights in Paramaribo and
visited places around Paramaribo, including the districts of
Commewijne (Frederiksdorp and Peperpot) and Brokopondo
(Brownsberg), the latter is considered to be the most probable
place of infection. She experienced onset of symptoms (headache
and high fever) on 28 February 2017 and was admitted to an
intensive care unit (University Medical Center) in the Netherlands
on 3 March 2017 with liver failure. The patient is currently in
critical condition.
Suriname is considered an area at risk for yellow fever and requires
a yellow fever vaccination certificate at entry for travellers over one
year of age arriving from countries with risk of yellow fever,
according to the WHO list of countries with risk of yellow fever
transmission; WHO also recommends yellow fever vaccination to
all travellers aged nine months and older. This is the first reported
case of yellow fever in Suriname since 1972.
Read more

UPCOMING EVENTS
International conference of Pharmacy (ICP-2017) organized by
School of Pharmaceutical Sciences, Lovely Professional
Univwersity, Punjab in collaboration with Society of
Pharmaceutical Education and Research (SPER) will be held on 7th
to 8th April, 2017.
ICMR sponsored 10th Annual Conference on Clinical
Pharmacology for Health Ageing will be held in Mumbai on 28th
April to 1st May, 2017.

Click here to go at the top

9
31-03-2017

DRUGS UPDATES
FDA Approves Ocrevus: (28th March, 2017)
The U.S. Food and Drug Administration (FDA) has approved
Ocrevus (ocrelizumab), a humanized monoclonal antibody
designed to selectively target CD20-positive B cells as the first and
only medicine for both relapsing and primary progressive forms of
multiple sclerosis.
Read more

CAMPUS NEWS
IRIS 2017:
GNIPST is going to organize the cultural fest IRIS 2017 on 5th and
6th April, 2017.
ICMR Sponsored National Seminar at Orisa:
Congratulations to Ranit Kundu who have got first prize in oral
presentation in ICMR sponsored National Seminar at Orissa.
Intra college cricket tournament 2017:
On 21st and 22nd February 2017 GNIPST organized Intra college
cricket tournament.
Congratulations to the winner:
B.Pharm 2nd year
Man of the match:
Soham Ray
Highest wicket Taker:
Shovon Ghosh
Highest run scorer:
Saikat Bera

Click here to go at the top

10
31-03-2017

Sardar Jodh Singh Trophy 2017:


On 17th February 2017 GNIPST participated in Sardar Jodh Singn
Trophy 2017 and played the cricket match against Asansol
Engineering College and GNIT.
Annual Sports Meet 2017:
On 14th and 15th February 2017 GNIPST organized Annual Sports
Meet 2017.
Congratulations to the following winner:
Flat Race 100 m for Boys:
1st: Suman Ghosh
2nd: Arijit Mitra Thakur
3rd: Arnab Ghosh
Flat Race 100 m for Girls:
1st: Moutan Roy
2nd: Manpreet Kaur
3rd: Kriti Prasad
Flat Race 200 m for Boys:
1st: Suman Ghosh
2nd: Arnab Ghosh
3rd: Abhiraj Pathak
Flat Race 200 m for Girls:
1st: Anjali Mondal
2nd: Moutan Roy
3rd: Kriti Prasad
3 Legged Race:
1st: Aindrila Bhowmick
Anjali Mondal
2nd: Poulami Sarkar
Pamolita Paul
rd
3 : Renu Sha

Click here to go at the top

11
31-03-2017

Sayani Das
Long Jump for Boys:
1st: Abu Sufian
2nd: Saikat Bera
3rd: Arijit Mitra Thakur
Long Jump for Girls:
1st: Sayani Das
2nd: Aindrila Bhowmick
3rd: Anjali Mondal
Skipping for Girls:
1st: Moutan Roy
2nd: Aindrila Bhowmick
3rd: Anjali Mondal
Shot put for Boys:
1st: Arijit Mitra Thakur
2nd: Bishal Kr. Singh
3rd: Abu Sufian
Shot put for Girls:
1st: Koyel Ghosh
2nd: Aindrila Bhowmick
3rd: Pamolita Paul
Discuss throw for Boys:
1st: Arijit Mitra Thakur
2nd: Monojit Dutta
3rd: Bishal Kr. Singh
Discuss throw for Girls:
1st: Nasrina Mondal
2nd: Aparupa Sinha
3rd: Kriti Prasad
Sack Race 50 m for Boys:
1st: Sneham Sen
Click here to go at the top

12
31-03-2017

2nd: Arijit Mitra Thakur


3rd: Maruf Billa Akunji
Sack Race 50 m for Girls:
1st: Kriti Prasad
2nd: Nasrina Mondal
3rd: Moutan Roy
Relay Race (4x100 m) for Boys:
Winner: Sneham Sen
Abhiraj Pathak
Arijit Mitra Thakur
Suman Ghosh
Relay Race (4x100 m) for Girls:
Winner: Kriti Prasad
Sayani Das
Nasima Mondal
Sunanda Konar
Go for Goal for Boys:
1st: Abhiraj Pathak
2nd: Arnab Ghosh
3rd: Subhankar Malakar
Balance Race 100 m for Girls:
1st: Aindrila Bhowmick
2nd: Pamolita Paul
3rd: Moutan Roy
Tug of War (Boys):
Winner: Arnab Mondal
Arnab Chakrabarty
Asif Iqbal
Ankit Chowdhury
Arnab Sarkar
Tug of War (Girls):
Click here to go at the top

13
31-03-2017

Winner: Aparupa Sinha


Priya Bardhan Roy
Poulami Sarkar
Pamolita Paul
Moutan Roy
Flat Race for /male Staff:
1st: Dr. Subhendu Bandyopadhyay
2nd: Debabrata Ghosh Dastidar
3rd: Dipanjan Mondal
Hit the Stamp for Male Staff:
1st: Dipanjan Mondal
2nd: Debabrata Ghosh Dastidar
3rd: Dr. Asis Bala
Hit the Stamp for Female Staff:
1st: Anuranjita Kundu
2nd: Prapti Chakraborty
3rd: Rakhi
Balance Race for Female Staff:
1st: Moumita Chowdhury
2nd: Priyanka Ray
3rd: Jeenatara Begum
Hari Bhanga for Female Staff:
1st: Sumana Roy
2nd: Priyanka Ray
3rd: Rakhi
Tug of War (Female Staff):
Winner: Dr. Sumana Chatterjee
Dr. Sriparna Kundu Sen
Sumana Roy
Jeenatara Begum
Moumita Chowdhury
Click here to go at the top

14
31-03-2017

Jaya Banerjee
Satabdi
Sunknowledge Pvt. Ltd.:
Cngratulations to the students who got the job of Sonknowledge
Pvt. Ltd.
1. Aishwarya Datta
2. Debjani Saha
3. Sayani Banerjee
4. Priya Dey
5. Anurag T K Baidya
6. Diptarco Singha
7. Soumyadeep Bhattachrya
8. Soumava Bhattacharya
9. Aniruddha Bhar
10. Dibyojyoti Chatterjee
QUIZ organized by GNIDSR:
Congratulations to Pratik Nandi and Bhaskar, who have acquired
2nd position in quiz competition organized by GNIDSR.
Reminiscence 2017:
On 12th February, 2017 GNIPST celebrated Reunion programme.
GPAT 2017:
The following B.Pharm. final year students have qualified, GPAT-
2017. We congratulate them all.
Anjali Mondal
Anurag T K Baidya
Arpita Ghosal
Rudradip Das
Swati Abat
Tanaya Palit
Tanmoy Saha

Click here to go at the top

15
31-03-2017

Cognizant:
Congratulations to the students who got the job of Cognizant..
NBA Accreditation:
NBA has accreditated GNIPST.
Debate competition:
On 19th November, 2016 our student Pratik Nandy and Dippoman
Guha was participated in All India University debate Competition
organized by Calcutta Debate Circle.
International seminar 2016:
International seminar on Global Advancement in Pharmaceutical
research and startup organized by GNIPST in collaboration with
IPGA was held on 22nd October, 2016 at GNIPST auditorium.
NBA visit:
The experts of National Board of Accreditation or NBA will be
going to visit GNIPST on 24th September and 25th September,
2016.
Freshers welcome programme:
On 12th September GNIPST organized the Freshers welcome
programme Kulrav 2k16.
GNIPST Football Match 2016:
On 31st August and 1st September GNIPST sports club organized a
football match. The winner of the football match was B.Pharm 3rd
year.
Recent Trends in Pharmaceutical Research:
A Science Awareness Programme comprising of seminar on
Recent Trends in Pharmaceutical Research was organized by
GNIPST in collaboration with National Academy of Science India
(NASI) on 30th august, 2016 from 2 pm to 4.30 pm at GNIPST
auditorium. Plantation programme was also organized by Eco club.
Dr. Hemanta Kumar Majumder, gave his valuable lecture on
Click here to go at the top

16
31-03-2017

Modern Biology & its Evolution and Dr. Pijush K Das delivered
his lecture on Site specific Drug Targeting Magic Bullet
approach.
World Photography Day celebration:
On 19th August 2016 GNIPST celebrated World Photography Day
at Dakhineswar.
Friendly Football Match:
On 15th August 2016 GNIPST organised a friendly football match
with Alumni members.
Farewell 2016:
On 25th May 2016 GNIPST celebrated the farewell programme for
the final year students. Best of luck to all final year students for
their future life.
ALUMNI MEMBERS 2016:
Congratulations to new Alumni Members of GNIPST.
Placement Record 2016:
SL COMPANY NAME NUMBER OF NUMBER OF JOB
NO STUDENT STUDENT PROFILE
APPEARED/APPLIED SELECTED
1 DR. LAL PATH LAB 64 7 Sales,
Marketing and
office assistant
2 APOLLO 36 25 Hospital and
PHARMACY retail chain
pharmacist
3 ABBOTT INDIA 74 03 Sales and
Marketing

4 HETERO DRUGS 18 18 (Waiting Production,


for final QC and QA
interview)
5 ERIS LIFE SCIENCES 01 01 (Joined) Sales and
Marketing

6 JUPITER 05 01 (Joined) Production,


PHARMACEUTICALS QC and QA

Click here to go at the top

17
31-03-2017

7 GOVT PHARMACIST 4 4 (Joined) Hospital


Pharmacist

8 ALCHEMIST EYE 2 2 (Waiting for Hospital


HOSPITAL final Pharmacist
interview)
9 OPTIVAL HEALTH 21 21 Community
SOLUTIONS PVT. Pharmacist
LTD. (MEDPLUS)
10 NESTLE INDIA LTD 08 02 Nutrition
Officer
Trainee
11 LUPIN 01 01 Sales and
Marketing

12 GSK 05 02 (1 of them Sales and


PHARMACEUTICAL already joined) Marketing
LTD
13 OAK 06 02 (Joined) Sales and
PHARMACEUTICAL Marketing

IPA Bengal Pharma & Healthcare trust scholarship 2016:


Congratulations to Rudradip Das, student of B.Pharm 3rd year has
been awarded IPA Bengal Pharma & Healthcare trust scholarship
2016.
Accreditation by NAAC:
SL. NAME OF STATE CGPA(out GRADE
NO. THE of scale 4)
INSTITUTE
01 Guru Nanak West 2.70 B
Institute of Bengal
Pharmaceutical
Science And
Technology,
Kolkata-700114

Click here to go at the top

18
31-03-2017

GPAT 2016 Result:


The following B.Pharm. final year students have qualified, GPAT-
2016. We congratulate them all.
Aishika Datta
Mainak Chatterjee
Indira Saha
Priyanka De
Aheli Mukherjee
Soumya Guha
Debanjana Das
Debalina Datta
Evana Patra
Himadrija Chatterjee

IRIS 2016:
GNIPST organized colllege fest IRIS 2016 from 11th to 13th March,
2016.
Result of different events:
Intracollege Quiz competition:
1st: Arani Roy and Dipayan Nath
2nd: Bhaskar Singha and Pratik Nandi
Intracollege Painting competition:
1st: Swagata Paul
2nd: Aviraj Pathak
3rd: Dippyoman Guha
Group Dance Competition:
Karma Group
Intercollege Solo Dance Competition:
1st : Monodipa Ghosh
2nd: Aditya Paul (NIT)
Antaksari Competition:
1st: Sunanda and Aparupa

Click here to go at the top

19
31-03-2017

2nd: Meghna and Joyita


3rd: Arpita and Pami
Intercollege Solo Singing Competition:
1st: Arpita Sarkar
2nd: Arvind Raj (Sudhir Chandra College)
3rd: Priyam Mondal (Supreme College)
Intercollege Band Competition:
1st: D Errors
2nd: Mukti
3rd: GNIPST band
Fashion:
Best Male: Md. Nadeem Shah
Best Female: Sweta
Best Couple: Md. Nadeem Shah and Susmita Kar
Blood donation Camp 2016:
On 4th March 2016 Social Service club and Alumni Association
of GNIPST organized a Blood donation camp in association with
Association of voluntary Blood Donars, West Bengal.
National Assessment and Accreditation Council (NAAC):
A NAAC peer team completed a three-day inspection (17th
February to 19th February, 2016) of GNIPST to evaluate its
academic credibility and infrastructure on Friday.
Saraswati Puja 2016:
On 13th February 2016 the students of GNIPST celebrated
Saraswati Puja at GNIPST campus.

Click here to go at the top

20
31-03-2017

STUDENTS SECTION
WHO CAN ANS WER FIRS T????

Identify the person

Answer of Previous Issues Image:


20th March

Send your thoughts/


Quiz/Puzzles/games/write-ups or any other
contributions for Students Section& answers
of this Section at gnipstbulletin@gmail.com

EDITORS NOTE
It is a great pleasure for me to publish the 3rd issue of 65th Volume
of GNIPST BULLETIN. All the followers of GNIPST BULLETIN
are able to avail the bulletin through facebook account GNIPST
bulletin I am very much thankful to all the GNIPST members and
readers who are giving their valuable comments, encouragements
and supports. I am also thankful to Dr. Abhijit Sengupta, Director
of GNIPST for his valuable advice and encouragement. Special
thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar
and Mr. Soumya Bhattacharya for their kind co-operation and
technical supports. Thank you Mr. Soumya Bhattacharya for the
questionnaires of the student section. An important part of the

Click here to go at the top

21
31-03-2017

improvement of the bulletin is the contribution of the readers. You


are invited to send in your write ups, notes, critiques or any kind of
contribution for the forthcoming special and regular issue.
ARCHIVE
OTHERS:
AICTE has sanctioned a release of grant under Research
Promotion Scheme (RPS) during the financial year 2012-13to
GNIPST as per the details below:
a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical
Science & Technology.
b. Principal Investigator: Dr. LopamudraDutta.
c. Grant-in-aid sanctioned:Rs. 16,25000/- only
d. Approved duration: 3 years
e. Title of the project: Screening and identification of potential
medicinal plant of Purulia & Bankura districts of West Bengal
with respect to diseases such as diabetes, rheumatism, Jaundice,
hypertension and developing biotechnological tools for enhancing
bioactive molecules in these plants.
Activity Clubs of GNIPST:
Name of Club Member Faculty
CULTURAL Ms. Priyanka Ray
DEBATE AND EXTEMPORE Mr. Soumya Bhattacharya
ECO Ms. Sumana Roy
LITERARY AND PAINTING Ms. Jeenatara Begum
PHOTOGRAPHY Ms. Sanchari Bhattacharya and
Mr. Abir Koley
SCIENCE AND INNOVATIVE Mr. Samrat Bose
MODELLING
SOCIAL SERVICES Dr. Asis Bala
SPORTS Mr. Debabrata GhoshDastidar

Click here to go at the top

22

You might also like